CA Patent

CA2958666C — Crystalline forms of 6-((6,7-dimethoxyquinazolin-4-yl)oxy)-n,2-dimethylbenzofuran-3-carboxamide

Assigned to Hutchmed Ltd · Expires 2020-10-06 · 6y expired

What this patent protects

Crystalline forms of compound 6-(6,7-dimethoxyquinazolin-4-yloxy)-N,2- dimethylbenzofuran-3-carboxamide, pharmaceutical compositions and the methods of preparation and the use thereof.

USPTO Abstract

Crystalline forms of compound 6-(6,7-dimethoxyquinazolin-4-yloxy)-N,2- dimethylbenzofuran-3-carboxamide, pharmaceutical compositions and the methods of preparation and the use thereof.

Drugs covered by this patent

Patent Metadata

Patent number: CA2958666C
Jurisdiction: CA
Classification: —
Expires: 2020-10-06
Drug substance claim: No
Drug product claim: No
Assignee: Hutchmed Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.